Discover the most anticipated breast cancer research at SABCS 2025, featuring groundbreaking abstracts in HR+, HER2+, and ...
MedPage Today on MSN
Transformation of Lung Cancer; What the OR Team Had to Say; Microplastics and Cancer
The FDA granted traditional approval to pirtobrutinib (Jaypirca) for relapsed/refractory chronic lymphocytic leukemia/small ...
Roche is being called on to drop the price of its breast cancer drug Kadcyla in the UK so that patients can keep receiving the treatment. The drug is set to be 'de-listed' from England's Cancer Drugs ...
Roche (RHHBY) is upgraded to Buy as strong 2025 growth, new drug launches, and obesity drug potential create an attractive ...
A campaign push by some Republicans to make contraceptive drugs available without a prescription has some support from medical groups despite objections from women's health advocates. New York City ...
Roche stock could be interesting for patient investors. Learn more about its outlook, pipeline prospects, and upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback